COVID-19 oral meds market good pill to swallow

Eyeing the huge market potential, pharmaceutical enterprises are ramping up efforts to grab a share of the COVID-19 preventative oral medicine market in China and the rest of the world.

Related Keywords

China ,Henan ,Philippines ,Shanghai ,Wuhan ,Hubei ,Chinese ,Deng Zhidong ,Junshi Biosciences ,Simcere Pharmaceutical Group Ltd ,Chinese Academy Of Sciences ,Pfizer ,Fujian Cosunter Pharmaceutical Co Ltd ,Genuine Biotech Co Ltd ,Frontier Biotechnologies Inc ,National Medical Products Administration ,Shanghai Institute Of Materia Medica ,Boao Medical Technology Co ,Kintor Pharmaceutical Ltd ,Guangdong Zhongsheng Pharmaceutical Co Ltd ,Wuhan Institute Of Virology ,Essence Securities ,Nanjing Based Simcere Pharmaceutical Group Ltd ,Chinese Academy ,Shanghai Institute ,Materia Medica ,Wuhan Institute ,Shanghai Based Junshi Biosciences ,China Business Herald New Weekly ,Bo Ao Medical Technology ,Covid 19 ,Coral ,Pharmaceutical ,Drugs ,Medicine ,Preventative ,Enterprises ,Market ,Clinical ,